BioDlogics licenses stem cell products to Amedica/US Spine; Predictive Biosciences licenses Epigenomics AG's prostate cancer biomarker.
Amedica/US Spine and Predictive Biosciences announced licensing and distribution deals with a pair of other companies.
Salt Lake City-based spinal reconstruction implant maker Amedica/US Spine intends to distribute spinal fusion, adhesion barrier and nerve protection products based on BioDlogics' human cellular and tissue-based products, or allografts.
Get the complete picture with a MassDevice Plus membership. Registered users can login here.